Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-07-10 1:14 pm Purchase | 2024-06-28 | 13G | NovoCure Limited NVCR | VANGUARD GROUP INC | 11,127,354 10.340% | 1,368,267 (+14.02%) | Filing History |
| 2024-07-08 4:32 pm Purchase | 2024-06-30 | 13G | NovoCure Limited NVCR | BlackRock Inc. BLK | 12,215,856 11.400% | 3,423,821 (+38.94%) | Filing |
| 2024-02-13 5:09 pm Purchase | 2023-12-29 | 13G | NovoCure Limited NVCR | VANGUARD GROUP INC | 9,759,087 9.130% | 211,751 (+2.22%) | Filing History |
| 2024-02-09 6:14 pm Sale | 2024-02-07 | 13G | NovoCure Limited NVCR | Capital World Investors | 3,276,996 3.100% | -2,557,084 (-43.83%) | Filing History |
| 2024-02-09 6:03 pm Purchase | 2024-02-07 | 13G | NovoCure Limited NVCR | Capital International Investors | 8,896,076 8.300% | 740,167 (+9.08%) | Filing History |
| 2024-02-09 11:32 am Purchase | 2023-12-31 | 13G | NovoCure Limited NVCR | BlackRock Inc. BLK | 8,792,035 8.200% | 1,186,610 (+15.60%) | Filing |
| 2024-02-09 09:28 am Purchase | 2024-02-08 | 13G | NovoCure Limited NVCR | FMR LLC | 15,962,765 14.937% | 219,251 (+1.39%) | Filing History |
| 2023-12-11 06:19 am Sale | 2023-12-11 | 13G | NovoCure Limited NVCR | Capital World Investors | 5,834,080 5.500% | -7,065,315 (-54.77%) | Filing History |
| 2023-11-09 06:15 am Sale | 2023-10-31 | 13G | NovoCure Limited NVCR | BAILLIE GIFFORD & CO | 5,095,777 4.770% | -3,768,065 (-42.51%) | Filing History |
| 2023-02-13 3:54 pm Sale | 2023-02-14 | 13G | NovoCure Limited NVCR | Capital International Investors | 8,155,909 7.800% | -3,375,166 (-29.27%) | Filing History |
| 2023-02-13 2:49 pm Purchase | 2023-02-14 | 13G | NovoCure Limited NVCR | Capital World Investors | 12,899,395 12.300% | 176,181 (+1.38%) | Filing History |
| 2023-02-09 12:01 pm Purchase | 2023-02-09 | 13G | NovoCure Limited NVCR | FMR LLC | 15,743,514 14.999% | 5,006,810 (+46.63%) | Filing History |
| 2023-02-09 11:27 am Purchase | 2022-12-30 | 13G | NovoCure Limited NVCR | VANGUARD GROUP INC | 9,547,336 9.100% | 1,654,023 (+20.95%) | Filing History |
| 2023-01-31 1:58 pm Purchase | 2022-12-31 | 13G | NovoCure Limited NVCR | BlackRock Inc. BLK | 7,605,425 7.200% | 916,069 (+13.69%) | Filing |
| 2023-01-23 10:49 am Sale | 2022-12-30 | 13G | NovoCure Limited NVCR | BAILLIE GIFFORD & CO | 8,863,842 8.450% | -751,326 (-7.81%) | Filing History |
| 2022-04-11 09:01 am Purchase | 2022-04-08 | 13G | NovoCure Limited NVCR | FMR LLC | 10,736,704 10.281% | 2,926,367 (+37.47%) | Filing History |
| 2022-02-11 2:48 pm Purchase | 2022-02-14 | 13G | NovoCure Limited NVCR | Capital World Investors | 12,723,214 12.300% | 1,694,783 (+15.37%) | Filing History |
| 2022-02-11 11:19 am Purchase | 2022-02-14 | 13G | NovoCure Limited NVCR | Capital International Investors | 11,531,075 11.100% | 822,013 (+7.68%) | Filing History |
| 2022-02-10 08:27 am Sale | 2021-12-31 | 13G | NovoCure Limited NVCR | VANGUARD GROUP INC | 7,893,313 7.600% | -350,657 (-4.25%) | Filing History |
| 2022-02-09 09:22 am Sale | 2022-02-08 | 13G | NovoCure Limited NVCR | FMR LLC | 7,810,337 7.522% | -1,835,049 (-19.03%) | Filing History |